90 related articles for article (PubMed ID: 9118150)
1. [The cardiac autocrine-paracrine system in the development of hypertrophy].
Neri Serneri GG; Modesti PA; Boddi M
Cardiologia; 1997 Jan; 42(1):11-9. PubMed ID: 9118150
[No Abstract] [Full Text] [Related]
2. [Role of endothelin in the development of cardiac hypertrophy].
Hasegawa H; Komuro I
Nihon Rinsho; 2004 Sep; 62 Suppl 9():617-21. PubMed ID: 15506460
[No Abstract] [Full Text] [Related]
3. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
4. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
Rubattu S; Volpe M; Raman V; Lindpaintner K
Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
[No Abstract] [Full Text] [Related]
5. The renin-angiotensin system and cardiac hypertrophy.
Yamazaki T; Komuro I; Shiojima I; Yazaki Y
Heart; 1996 Nov; 76(3 Suppl 3):33-5. PubMed ID: 8977363
[No Abstract] [Full Text] [Related]
6. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
[TBL] [Abstract][Full Text] [Related]
7. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
Haddad GE; Blackwell K; Bikhazi A
Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies.
Sugden PH
J Card Fail; 2002 Dec; 8(6 Suppl):S359-69. PubMed ID: 12555146
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin system as a mediator of renal injury in hypertension.
Gharavi A; Klotman P
Mt Sinai J Med; 1998 Mar; 65(2):118-24. PubMed ID: 9520515
[No Abstract] [Full Text] [Related]
10. Update on local cardiac renin-angiotensin system.
Ruzicka M; Leenen FH
Curr Opin Cardiol; 1997 Jul; 12(4):347-53. PubMed ID: 9263646
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II as a cardiovascular risk factor.
Gavras I; Gavras H
J Hum Hypertens; 2002 May; 16 Suppl 2():S2-6. PubMed ID: 11967726
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blocking agents in regression of cardiac hypertrophy--how and why?
Paul B; Goyal RK
Indian Heart J; 2000; 52(1):19-22. PubMed ID: 10820928
[No Abstract] [Full Text] [Related]
13. Angiotensin blocking drugs and the heart beyond 2000.
Morgan TO; Delbridge LM
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S243-7. PubMed ID: 9892172
[TBL] [Abstract][Full Text] [Related]
14. The role of the AT1 angiotensin receptor in cardiac hypertrophy: angiotensin II receptor or stretch sensor?
Hunyady L; Turu G
Trends Endocrinol Metab; 2004 Nov; 15(9):405-8. PubMed ID: 15519886
[TBL] [Abstract][Full Text] [Related]
15. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems.
Xiang W; Kong J; Chen S; Cao LP; Qiao G; Zheng W; Liu W; Li X; Gardner DG; Li YC
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E125-32. PubMed ID: 15367398
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy.
Zou Y; Takano H; Akazawa H; Nagai T; Mizukami M; Komuro I
Endocr J; 2002 Feb; 49(1):1-13. PubMed ID: 12008744
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
Roks A; Buikema H; Pinto YM; van Gilst WH
Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561
[TBL] [Abstract][Full Text] [Related]
18. Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system.
De Mello WC
J Mol Cell Cardiol; 2004 Aug; 37(2):431-8. PubMed ID: 15276013
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism involved in the onset of heart failure].
Sasayama S
Nihon Naika Gakkai Zasshi; 1998 Sep; 87(9):1667-81. PubMed ID: 9816833
[No Abstract] [Full Text] [Related]
20. Dual effects of angiotensin II type 2 receptor on cardiovascular hypertrophy.
Inagami T; Senbonmatsu T
Trends Cardiovasc Med; 2001 Nov; 11(8):324-8. PubMed ID: 11728881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
